
Dr. Connie Eaves was inducted into The Royal Society for her development of robust functional methods to quantify and characterize distinct types of primitive blood and mammary cell precursors.
On May 11, 2011, University of British Columbia professor Connie Eaves was inducted into The Royal Society for her development of robust functional methods to quantify and characterize distinct types of primitive blood and mammary cell precursors. Induction into The Royal Society includes among its ranks other esteemed scientists including Stephen Hawking, Albert Einstein and Charles Darwin.
Dr. Eaves, also a distinguished scientist at BC Cancer’s Terry Fox Laboratory, has received another prestigious accolade. On May 6, the Royal Society in the UK announced their 2021 list of Fellows and Foreign Members. Dr. Eaves becomes one of the 52 Fellows elected from institutions across UK, the Commonwealth and around the world.
The Royal Society is a Fellowship of many of the world’s most eminent scientists and is the oldest scientific academy in continuous existence. Fellow inductees include Stephen Hawking, Isaac Newton, Charles Darwin, and Albert Einstein among others.
The Royal Society was founded in the 1660s with the intention to recognize, promote, and support excellence in science and to encourage the development and use of science for the benefit of humanity. It has played a part in some of the most fundamental, significant, and life-changing discoveries in scientific history and Royal Society scientists continue to make outstanding contributions to science in many research areas.
Dr. Connie Eaves is recognized for her development of robust functional methods to quantify and characterize distinct types of primitive blood and mammary cell precursors – now considered gold standards. Their use has enabled many discoveries, including Dr. Eaves’ first demonstration of quiescent malignant stem cells from studies of patients with chronic myeloid leukemia. Currently, her group is exploiting new ways of prospectively analysing the process of human leukemia and breast cancer development from genetically engineered normal human cells.
Dr. Eaves is already a Fellow of the Royal Societies of Canada (1994) and Edinburgh (2015), and has received may other awards including the Noble and Chew-Wei Prizes for Cancer Research, the International CML Foundation Rowley Prize, the American Society of Hematology’s Stratton Lifetime Achievement and E Donnall Thomas Awards, and the 2019 Gairdner-Wightman award.
In 2018 she was inducted into the Canadian Medical Hall of Fame and in 2019 she was named one of Chatelaine’s Women of the Year. This month she was also awarded an honorary doctorate by Acadia University and named as a University Scholar at UBC.
Tags:
Source: University of British Columbia
Credit: Photo: Dr. Connie Eaves, courtesy of the University of British Columbia.
